![]() ![]() A new generation of tests supports healthcare providers in choosing medications based on molecular characteristics of diseases and in monitoring treatments. Your partner for molecular diagnostic development and commercialization Our extensive range of OEM instruments, reagents, and services can accelerate your time to market and ensure long-term security of supply. The tests developed for oncology, virology, Human papilloma virus (HPV), microbiology and for screening blood products are used around the world by researchers, doctors, patients, hospitals, laboratories and blood banks. It is increasingly evident that molecular diagnostics, that is, the use of diagnostic testing to understand the molecular mechanisms of an individual patient's disease, will be pivotal in the delivery of safe and effective therapy for many diseases in the future. Molecular diagnostics is referred to as the detection of genomic variants, aiming to facilitate detection, diagnosis, subclassification, prognosis, and. The Molecular Diagnostics Division uses a variety of nucleic acid assays including a range of extraction methods, qualitative and quantitative PCR, Sanger and. Pioneering new fields/ applications for Next Generation Sequencingįor molecular diagnostics Roche develops and produces innovative tests based on the Nobel Prize-winning discovery of the polymerase chain reaction (PCR). The Molecular Diagnostics Laboratory is equipped with state-of-the-art equipment and facilities including high-throughput automated extraction and liquid. New technologies to measure nucleic acid modifications SLUCares DNA Diagnostic Laboratory offers a variety of tests that utilize molecular biology techniques for genetic, microbiological and oncological. New platforms and reagents for improved nucleic acid testing ![]() Isolation, enrichment and amplification technologies for nucleic acid testing molecular diagnostics liquid biopsy assays biomarkers medical screening genetic testing prenatal diagnosis precision and personalized medicine. Novel technologies for handling and storage of samples prior to nucleic acid testing We aim to make next-generation sequencing routine and develop a complete sequencing solution from “Sample In” to “Result Out”. By simplifying workflows and expanding assay menus, we are broadening access to genomic data. Roche's legacy of innovation includes transforming next-generation sequencing and its applications. Diagnostics tailored to individual genetic and disease profiles ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |